Skip to main content

Table 1 Patient characteristics

From: Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases

 

Total

N = 10,325

Resection

Metastasis

No Resection

N = 7419

Resection

N = 2906

Pa

Liver

N = 8195

Lung

N = 807

Both

N = 1323

Pa

Resection

No

7419 (71.9%)

7419 (100%)

5695 (69.5%)

663 (82.2%)

1061 (80.2%)

< 0.001

Yes

2906 (28.1%)

2906 (100%)

 

2500 (30.5%)

144 (17.8%)

262 (19.8%)

 

Metastasis

Liver only

8195 (79.4%)

5695 (76.8%)

2500 (86.0%)

< 0.001

8195 (100%)

Lung only

807 (7.8%)

663 (8.9%)

144 (5.0%)

 

807 (100%)

 

Liver and Lung

1323 (12.8%)

1061 (14.3%)

262 (9.0%)

 

1323 (100%)

 

Tumor localization

Right colon

3485 (33.8%)

2602 (35.1%)

883 (30.4%)

< 0.001

2808 (34.3%)

220 (27.3%)

457 (34.5%)

< 0.001

Transverse

1401 (13.6%)

1005 (13.5%)

396 (13.6%)

 

1140 (13.9%)

98 (12.1%)

163 (12.3%)

 

Left colon

3311 (32.1%)

2346 (31.6%)

965 (33.2%)

 

2666 (32.5%)

231 (28.6%)

414 (31.3%)

 

Rectosigmoid

966 (9.4%)

680 (9.2%)

286 (9.8%)

 

736 (9.0%)

88 (10.9%)

142 (10.7%)

 

Rectum

1162 (11.3%)

786 (10.6%)

376 (12.9%)

 

845 (10.3%)

170 (21.1%)

147 (11.1%)

 

T-Stage

T1 to T3

6643 (64.3%)

4727 (63.7%)

1916 (65.9%)

0.034

5348 (65.3%)

532 (65.9%)

763 (57.7%)

< 0.001

T4

3682 (35.7%)

2692 (36.3%)

990 (34.1%)

 

2847 (34.7%)

275 (34.1%)

560 (42.3%)

 

N-Stage

N0

2103 (20.4%)

1439 (19.4%)

664 (22.8%)

< 0.001

1654 (20.2%)

230 (28.5%)

219 (16.6%)

< 0.001

N+

8222 (79.6%)

5980 (80.6%)

2242 (77.2%)

 

6541 (79.8%)

577 (71.5%)

1104 (83.4%)

 

Grade

G1/2

7715 (74.7%)

5450 (73.5%)

2265 (77.9%)

< 0.001

6090 (74.3%)

615 (76.2%)

1010 (76.3%)

0.118

G3/4

2610 (25.3%)

1969 (26.5%)

641 (22.1%)

 

2105 (25.7%)

192 (23.8%)

313 (23.7%)

 

Chemo- and/or

No

2842 (27.5%)

2294 (30.9%)

548 (18.9%)

< 0.001

2216 (27.0%)

235 (29.1%)

391 (29.6%)

0.437

Radiotherapy

Yes

7483 (72.5%)

5125 (69.1%)

2358 (81.1%)

 

5979 (73.0%)

572 (70.9%)

932 (70.4%)

 

Year of diagnosis

2010–2012

5304 (51.4%)

3915 (52.8%)

1389 (47.8%)

< 0.001

4279 (52.2%)

365 (45.2%)

660 (49.9%)

0.005

2013–2015

5021 (48.6%)

3504 (47.2%)

1517 (52.2%)

 

3916 (47.8%)

442 (54.8%)

663 (50.1%)

 

Age (years)

< 50

1799 (17.4%)

1130 (15.2%)

669 (23.0%)

< 0.001

1474 (18.0%)

120 (14.9%)

205 (15.5%)

0.005

50–64

4065 (39.4%)

2843 (38.3%)

1222 (42.1%)

 

3241 (39.5%)

285 (35.3%)

539 (40.7%)

 

65–79

3247 (31.4%)

2448 (33.0%)

799 (27.5%)

 

2525 (30.8%)

285 (35.3%)

437 (33.0%)

 

80+

1214 (11.8%)

998 (13.5%)

216 (7.4%)

 

955 (11.7%)

117 (14.5%)

142 (10.7%)

 

Gender

Male

5693 (55.1%)

4159 (56.1%)

1534 (52.8%)

0.003

4585 (55.9%)

387 (48.0%)

721 (54.5%)

0.003

Female

4632 (44.9%)

3260 (43.9%)

1372 (47.2%)

 

3610 (44.1%)

420 (52.0%)

602 (45.5%)

 

Ethnicity

Caucasian

7787 (75.4%)

5576 (75.2%)

2211 (76.1%)

0.336

6237 (76.1%)

591 (73.2%)

959 (72.5%)

0.117

African-American

1555 (15.1%)

1117 (15.1%)

438 (15.1%)

 

1219 (14.9%)

115 (14.3%)

221 (16.7%)

 

Other/Unknown

983 (9.5%)

726 (9.8%)

257 (8.8%)

 

739 (9.0%)

101 (12.5%)

143 (10.8%)

 

Marital status

Married

5583 (54.1%)

3925 (52.9%)

1658 (57.1%)

< 0.001

4501 (54.9%)

399 (49.4%)

683 (51.6%)

0.061

Single/Widowed

3057 (29.6%)

2256 (30.4%)

801 (27.6%)

 

2398 (29.3%)

259 (32.1%)

400 (30.2%)

 

Other/Unknown

1685 (16.3%)

1238 (16.7%)

447 (15.4%)

 

1296 (15.8%)

149 (18.5%)

240 (18.1%)

 
  1. n (percent)
  2. aChi-squared test